Immunosuppressive therapy for pharmacoresistant epilepsy due to primary antiphospholipid syndrome. (2nd November 2015) - Falip, M; Miró, J; Jaraba, S; Cusó, S; Capdevila, O; Graus, F; Martínez-Yélamos, A